Growth Hormone Releasing Peptide 6

This page shows anti-doping rule violation data we have registered for Growth Hormone Releasing Peptide 6.

Number of cases in Growth Hormone Releasing Peptide 6 Last 10 Years

Growth Hormone Releasing Peptide 6

Growth Hormone Releasing Peptide 6 ranks #89 globally among prohibited substances, with 26 registered cases (0.2% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,710 verified cases. USA leads with 5 cases, while Cycling is the most affected sport (5 cases).

Cases of Growth Hormone Releasing Peptide 6 by Sport
Cycling
5
Rugby
4
Weightlifting
4
Tennis
2
Canoe/Kayak
2
Top Sport: Cycling

5

Cycling cases

0%

Of all violations

26

Total Growth Hormone Releasing Peptide 6 cases
Cycling's share of Growth Hormone Releasing Peptide 6 violations 0%
5 of 26

Cycling has the most recorded cases of Growth Hormone Releasing Peptide 6 violations globally, with 5 registered cases — 0% of all 26 verified cases.

Cases of Growth Hormone Releasing Peptide 6 by Country
USA
5
Russia
4
United Kingdom
3
Australia
2
Turkey
2
Top Country: USA

5

USA cases

19.2%

Of all violations

26

Total Growth Hormone Releasing Peptide 6 cases
USA's share of Growth Hormone Releasing Peptide 6 violations 19.2%
5 of 26

USA leads in Growth Hormone Releasing Peptide 6 violations globally, with 5 registered cases — 19.2% of all 26 verified cases.

Global Substance Ranking

Growth Hormone Releasing Peptide 6 ranks #89 of 358 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,364
#2 Methandienone
835
#3 Norandrosterone
781
#4 Testosterone
758
···
#89 Growth Hormone Releasing Peptide 6
25
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 88.5%
23 cases
Female 11.5%
3 cases
Analysis: has a notably higher proportion of male cases (88.5%) compared to the global average (80.2%), a difference of 8.3 percentage points. Global average: 80.2% male, 19.8% female
Average Suspension Length
51.8
months
Growth Hormone Releasing Peptide 6
30.1
months
Global average

The average suspension for Growth Hormone Releasing Peptide 6 violations is 51.8 months, longer than the global average of 30.1 months.

This prohibited substance is administered through injections and is used to stimulate the release of growth hormone by the pituitary gland.

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,710 verified anti-doping rule violations across all sports and all countries, and is updated regularly.